诺和诺德股价下跌高达7%，尽管其重磅减肥药销售目标为230亿美元

2026-09-21 · cnbc.com

这家丹麦公司试图让投资者相信，它能在自己开创的日益拥挤的领域中保持竞争力。

Novo shares fell as much as 7% on Monday after the company laid out new growth ambitions to revive its fortunes in the booming obesity drug market.

The Danish ...